BioCentury
ARTICLE | Financial News

Qiming leads Sino Biological's series A round

July 6, 2017 8:20 PM UTC

Sino Biological Inc. (Beijing, China) raised RMB200 million ($29.5 million) in a series A round led by Qiming Venture Partners. The company provides contract research services and manufactures biological products and reagents, including recombinant proteins, monoclonal antibodies and genetic vaccines, for drug R&D...